CD91.DE vs. LYP6.DE
CD91.DE (Amundi NYSE Arca Gold Bugs UCITS ETF Dist) and LYP6.DE (Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc) are both exchange-traded funds - CD91.DE is a Gold fund tracking the NYSE Arca Gold BUGS, while LYP6.DE is a Europe Equities fund tracking the STOXX® Europe 600. Both are passively managed. Over the past 5 years, CD91.DE returned 20.17%/yr vs 9.75%/yr for LYP6.DE. At a 0.20 correlation, their price movements are largely independent. CD91.DE charges 0.65%/yr vs 0.07%/yr for LYP6.DE.
Performance
CD91.DE vs. LYP6.DE - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CD91.DE achieves a 2.09% return, which is significantly lower than LYP6.DE's 7.48% return.
CD91.DE
- 1D
- 0.92%
- 1M
- -0.47%
- YTD
- 2.09%
- 6M
- 9.79%
- 1Y
- 67.95%
- 3Y*
- 40.18%
- 5Y*
- 20.17%
- 10Y*
- 12.49%
LYP6.DE
- 1D
- 0.57%
- 1M
- 3.11%
- YTD
- 7.48%
- 6M
- 10.06%
- 1Y
- 16.54%
- 3Y*
- 13.98%
- 5Y*
- 9.75%
- 10Y*
- —
CD91.DE vs. LYP6.DE - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist | 2.09% | 132.40% | 20.73% | 2.42% | -1.60% | -8.06% | 15.38% | 49.81% | -12.27% | -5.03% |
LYP6.DE Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc | 7.48% | 20.82% | 8.25% | 15.97% | -10.40% | 24.81% | -1.72% | 28.59% | -11.28% | 2.60% |
Correlation
The correlation between CD91.DE and LYP6.DE is 0.37, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.37 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.33 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.29 |
Correlation (All Time) Calculated using the full available price history since Sep 20, 2017 | 0.20 |
The correlation between CD91.DE and LYP6.DE shifts across timeframes, from 0.20 (all time) to 0.37 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CD91.DE vs. LYP6.DE — Risk / Return Rank
CD91.DE
LYP6.DE
CD91.DE vs. LYP6.DE - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) and Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc (LYP6.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CD91.DE | LYP6.DE | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.32 | ||
| Sortino ratioReturn per unit of downside risk | +0.18 | ||
| Omega ratioGain probability vs. loss probability | 1.27 | 1.24 | +0.02 |
| Calmar ratioReturn relative to maximum drawdown | 2.49 | 1.74 | +0.75 |
| Martin ratioReturn relative to average drawdown | 6.17 | 6.63 | -0.46 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CD91.DE | LYP6.DE | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.60 | 1.28 | +0.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.58 | 0.67 | -0.09 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.36 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.09 | 0.56 | -0.47 |
Drawdowns
CD91.DE vs. LYP6.DE - Drawdown Comparison
The maximum CD91.DE drawdown since its inception was -80.32%, which is greater than LYP6.DE's maximum drawdown of -35.51%. Use the drawdown chart below to compare losses from any high point for CD91.DE and LYP6.DE.
Loading charts...
Drawdown Indicators
| CD91.DE | LYP6.DE | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -80.32% | -35.51% | -44.81% |
Max Drawdown (1Y)Largest decline over 1 year | -27.16% | -9.45% | -17.71% |
Max Drawdown (3Y)Largest decline over 3 years | -27.16% | -16.26% | -10.90% |
Max Drawdown (5Y)Largest decline over 5 years | -39.56% | -20.71% | -18.85% |
Max Drawdown (10Y)Largest decline over 10 years | -55.46% | — | — |
Current DrawdownCurrent decline from peak | -23.41% | -1.62% | -21.79% |
Average DrawdownAverage peak-to-trough decline | -46.60% | -4.84% | -41.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 10.95% | 2.49% | +8.46% |
Volatility
CD91.DE vs. LYP6.DE - Volatility Comparison
Amundi NYSE Arca Gold Bugs UCITS ETF Dist (CD91.DE) has a higher volatility of 13.40% compared to Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc (LYP6.DE) at 4.35%. This indicates that CD91.DE's price experiences larger fluctuations and is considered to be riskier than LYP6.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CD91.DE | LYP6.DE | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.40% | 4.35% | +9.05% |
Volatility (6M)Calculated over the trailing 6-month period | 33.89% | 10.65% | +23.24% |
Volatility (1Y)Calculated over the trailing 1-year period | 42.29% | 12.90% | +29.39% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 34.31% | 14.41% | +19.90% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 34.40% | 15.86% | +18.54% |
CD91.DE vs. LYP6.DE - Expense Ratio Comparison
CD91.DE has a 0.65% expense ratio, which is higher than LYP6.DE's 0.07% expense ratio.
Dividends
CD91.DE vs. LYP6.DE - Dividend Comparison
CD91.DE's dividend yield for the trailing twelve months is around 0.13%, while LYP6.DE has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CD91.DE Amundi NYSE Arca Gold Bugs UCITS ETF Dist | 0.13% | 0.14% | 0.31% | 2.37% | 1.05% | 0.46% | 0.14% | 0.30% | 0.00% | 0.57% |
LYP6.DE Amundi Core STOXX Europe 600 (DR) UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CD91.DE and LYP6.DE have a correlation of 0.37, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, LYP6.DE is cheaper at 0.07% per year. The better choice depends on whether you care most about return, fees, risk, or income.
LYP6.DE is cheaper with a 0.07% expense ratio, compared with 0.65% for CD91.DE.
CD91.DE is categorized as Gold, while LYP6.DE is Europe Equities. CD91.DE tracks NYSE Arca Gold BUGS, while LYP6.DE tracks STOXX® Europe 600. Their fees differ too: 0.65% for CD91.DE and 0.07% for LYP6.DE.
Find the right allocation for CD91.DE and LYP6.DE
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer